论文部分内容阅读
骨髓抑制是肿瘤化疗引起的最常见的毒性反应,骨髓抑制后外周血及骨髓中多种细胞因子和造血因子水平表达发生变化[1]。我们在以往的临床工作中观察到高原地区患者似乎较平原地区患者更容易出现化疗后骨髓抑制[2,3],为探究高原地区患者化疗前
Myelosuppression is the most common toxic reaction caused by tumor chemotherapy. The expression of many cytokines and hematopoietic factors in peripheral blood and bone marrow after myelosuppression is changed [1]. In our previous clinical work, we observed that patients in the plateau seemed to be more prone to post-chemotherapy myelosuppression than patients in the plain [2,3]. In order to explore whether patients with plateau prior to chemotherapy